Constructivebio
Constructive Bio is seeking a Downstream Processing Scientist to develop, optimize, and scale-up microbial bioprocesses for recombinant therapeutic proteins and peptides. The role involves utilizing protein analytical techniques, supporting technology transfer to manufacturing, and contributing to technoeconomic assessments within a GMP environment. This position bridges scientific process development and commercialization goals to strengthen the route to market.
Headquarters
Cambridge, England, United Kingdom
Company Size
11-50 employees
Founded
2021
Constructive Bio is a Cambridge, UK synthetic biology company, spun out of the MRC Laboratory of Molecular Biology, that designs and manufactures proteins and long-chain peptides incorporating non-canonical amino acids (ncAAs) using Syn61, the world's first fully recoded genome. Their proprietary BioForge platform enables scalable biological production of complex proteins with novel chemistries — including site-specific conjugation, covalent binding, and improved metabolic stability — unlocking next-generation therapeutics, advanced materials, and sustainable manufacturing applications. By expanding the genetic code beyond what natural biology or AI can access alone, Constructive Bio partners with pharmaceutical and industrial companies to develop molecules that conventional synthesis cannot achieve.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Constructivebio.
55% below the average for this role